Jason Haas

Insider Reports History

Location
Cambridge, MA
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Jason Haas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Haas:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Director Common Stock 6,606 $721,044 $109.15 06 Jun 2025 Direct
Syros Pharmaceuticals, Inc. Chief Financial Officer Common Stock 0 $0 $2.09 18 Nov 2024 Direct
Syros Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Units 0 $0 $2.09 31 Oct 2024 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 5,783 06 Jun 2025 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 5,444 14 Jun 2024 Direct

Insider Reports Filed by Jason Haas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LGND LIGAND PHARMACEUTICALS INC 06 Jun 2025 2 $0 4 Director 10 Jun 2025, 19:20
SYRS Syros Pharmaceuticals, Inc. 18 Nov 2024 1 -$28,980 4 Chief Financial Officer 20 Nov 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2024 3 -$11,754 4 Chief Financial Officer 04 Nov 2024, 17:01
SYRS Syros Pharmaceuticals, Inc. 10 Sep 2024 3 +$161,240 4 Chief Financial Officer 12 Sep 2024, 17:00
LGND LIGAND PHARMACEUTICALS INC 14 Jun 2024 2 $0 4 Director 18 Jun 2024, 21:26
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2024 5 -$24,228 4 Chief Financial Officer 02 Apr 2024, 16:54
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2023 3 -$13,988 4 Chief Financial Officer 02 Nov 2023, 16:53
LGND LIGAND PHARMACEUTICALS INC 09 Jun 2023 2 $0 4 Director 13 Jun 2023, 18:53
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2023 3 -$1,607 4 Chief Financial Officer 04 Apr 2023, 18:57
SYRS Syros Pharmaceuticals, Inc. 16 Feb 2023 1 $0 4 Chief Financial Officer 21 Feb 2023, 15:21
SYRS Syros Pharmaceuticals, Inc. 06 Oct 2022 2 $0 4 Chief Financial Officer 11 Oct 2022, 16:37
LGND LIGAND PHARMACEUTICALS INC 29 Jun 2022 2 $0 4 Director 30 Jun 2022, 18:32
LGND LIGAND PHARMACEUTICALS INC 29 Jun 2022 0 $0 3 Director 29 Jun 2022, 19:33
SYRS Syros Pharmaceuticals, Inc. 15 Feb 2022 2 $0 4 Chief Financial Officer 17 Feb 2022, 15:07
SYRS Syros Pharmaceuticals, Inc. 12 Oct 2021 1 $0 4 Chief Financial Officer 13 Oct 2021, 16:06
SYRS Syros Pharmaceuticals, Inc. 12 Oct 2021 0 $0 3 Chief Financial Officer 13 Oct 2021, 16:04